Adamis Pharmaceuticals Corp

NASDAQ:ADMP   3:59:40 PM EDT
0.72
+0.03 (+3.77%)
Earnings Announcements

Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results And Provides Corporate Update

Published: 11/22/2021 22:06 GMT
Adamis Pharmaceuticals Corp (ADMP) - Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update.
Adamis Pharmaceuticals Corp - Under Our New Commercial Partner, We Have Seen Significant Sales Growth for Symjepi.
Adamis Pharmaceuticals Corp - Now Engaged in a Process of Selling Or Otherwise Disposing of Remaining Assets of US Compounding Business.
Revenue is expected to be $2.82 Million
Adjusted EPS is expected to be -$0.05

Next Quarter Revenue Guidance is expected to be $7.51 Million
Next Quarter EPS Guidance is expected to be -$0.03

More details on our Analysts Page.